New York, NY -- (SBWIRE) -- 12/26/2013 -- CaddyStocks.com is keen to discover penny stocks with the potential to make short and long-term gains. We’ve been improving our skills as traders and analysts for years, and we know – from experience – which indicators to look for. That’s why we’ve been able to choice some of the market’s biggest winners and send them to our followers before the rest of the market has any idea of what hit them. Here are some hot stocks to watch for: Atossa Genetics Inc (NASDAQ:ATOS), IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI), Generex Biotechnology Corporation (OTCMKTS:GNBT), Globalstar, Inc. (OTCMKTS:GSAT).
Atossa Genetics Inc (NASDAQ:ATOS) opened its last trade at the price of $2.81. Its closing price was $2.60 after gaining 11.11% for the day. The company traded with the total volume of 1.17 million shares, while its average trading volume remained 244.284 shares. Atossa Genetics, Inc. operates as a healthcare company that focuses on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer in the United States.
For How Long ATOS will Fight for Profitability? Read This Trend Analysis report
IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) percentage change surged 9.06% to close at $3.73 with the total traded volume of 1.15 million shares, along with average volume of 2.41 million shares. The 52 week range of the stock remained $1.50 - $6.46, while its day lowest price was $3.37. The share price hit the day highest price of $3.85. Intellipharmaceutics International Inc. engages in the research, development, and manufacture of novel and generic controlled and targeted release oral solid dosage drugs in Canada.
For How Long IPCI Gloss will Attract Investors? Find out via this report
Generex Biotechnology Corporation (OTCMKTS:GNBT) traded on volume of 1.12 million shares in the last session against average volume of 1.93 million shares. The company started its trading session with the price of $0.03 and closed at $0.0285 by scoring plunged -3.39%. Generex Biotechnology Corporation, a development stage company, is engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
Why Should Investors Buy GNBT After the Recent Fall? Just Go Here and Find Out
Globalstar, Inc. (OTCMKTS:GSAT) started its last trading session with the price of $1.83 and closed at $1.85 by scoring dropped -0.54%. The stock traded with total volume of 1.07 million shares, while the average trading volume remained 3.82 million shares. The beta value of this stock stands at 3.08. Day range for the stock was $1.81 - $1.86. Globalstar, Inc. provides mobile voice and data communications services through satellite worldwide.
Will GSAT Get Buyers Even After The Recent Rally? Find Out Here
CaddyStocks record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
The employees of CaddyStocks.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
The information contained in the website and in any reports is provided on an “as-is” basis and has not been verified by us. All information on profiled companies is provided by such companies, or is available from public sources and no representation; warranty or guaranty is made as to its accuracy or completeness. CaddyStocks.com is under no obligation to update any information or opinions contained herein. Investors should not rely solely on the information presented herein, but rather use such information as a starting point for doing additional independent research on the profiled companies in order to form investment strategies and decisions. Neither CaddyStocks.com nor any of its owners, operators, or affiliates shall be liable to any subscriber or reader for any losses or damages arising from the use of any information contained herein, caused in whole or part by CaddyStocks.com in procuring, compiling, interpreting, reporting, or delivering any of the information contained herein or otherwise delivered.
Read Full Disclaimer at: http://caddystocks.com/disclaimer.html/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)